Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.

Pelled G, Ben-Arav A, Hock C, Reynolds DG, Yazici C, Zilberman Y, Gazit Z, Awad H, Gazit D, Schwarz EM.

Tissue Eng Part B Rev. 2010 Feb;16(1):13-20. doi: 10.1089/ten.teb.2009.0156. Review.

2.

A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France.

Alt V, Donell ST, Chhabra A, Bentley A, Eicher A, Schnettler R.

Injury. 2009 Dec;40(12):1269-75. doi: 10.1016/j.injury.2009.02.007. Epub 2009 Jun 18.

PMID:
19539926
3.

A fibrin glue composition as carrier for nucleic acid vectors.

Schillinger U, Wexel G, Hacker C, Kullmer M, Koch C, Gerg M, Vogt S, Ueblacker P, Tischer T, Hensler D, Wilisch J, Aigner J, Walch A, Stemberger A, Plank C.

Pharm Res. 2008 Dec;25(12):2946-62. doi: 10.1007/s11095-008-9719-8. Epub 2008 Sep 10.

PMID:
18781379
4.

Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.

Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman JR.

Bone. 2008 May;42(5):921-31. doi: 10.1016/j.bone.2007.12.216. Epub 2008 Jan 5.

PMID:
18295562
5.

Gene therapy applications for fracture-healing.

Carofino BC, Lieberman JR.

J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:99-110. doi: 10.2106/JBJS.G.01546. Review.

PMID:
18292364
6.

Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models.

Ishihara A, Shields KM, Litsky AS, Mattoon JS, Weisbrode SE, Bartlett JS, Bertone AL.

J Orthop Res. 2008 Jun;26(6):764-71. doi: 10.1002/jor.20585.

7.

Tracking expression of virally mediated BMP-2 in gene therapy for bone repair.

Gamradt SC, Abe N, Bahamonde ME, Lee YP, Nelson SD, Lyons KM, Lieberman JR.

Clin Orthop Relat Res. 2006 Sep;450:238-45.

8.

Effect of BMP-2 gene transfer on bone healing in sheep.

Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E, Baltzer AW.

Gene Ther. 2006 Sep;13(17):1290-9. Epub 2006 Apr 27.

PMID:
16642029
9.

Direct percutaneous gene delivery to enhance healing of segmental bone defects.

Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans CH.

J Bone Joint Surg Am. 2006 Feb;88(2):355-65.

PMID:
16452748
10.

Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.

Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, Herkowitz HN, Phillips F, Hilibrand A, Albert TJ, Wetzel T, McCulloch JA.

Spine (Phila Pa 1976). 2005 Dec 15;30(24):2709-16.

PMID:
16371892
11.

Gene therapy progress and prospects: electroporation and other physical methods.

Wells DJ.

Gene Ther. 2004 Sep;11(18):1363-9. Review.

PMID:
15295618
12.

Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.

Ono I, Yamashita T, Jin HY, Ito Y, Hamada H, Akasaka Y, Nakasu M, Ogawa T, Jimbow K.

Biomaterials. 2004 Aug;25(19):4709-18.

PMID:
15120517
13.

Progress and prospects: naked DNA gene transfer and therapy.

Herweijer H, Wolff JA.

Gene Ther. 2003 Mar;10(6):453-8. Review.

PMID:
12621449
14.

Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.

Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group.

J Bone Joint Surg Am. 2002 Dec;84-A(12):2123-34.

PMID:
12473698
15.

In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Audouy SA, de Leij LF, Hoekstra D, Molema G.

Pharm Res. 2002 Nov;19(11):1599-605. Review.

PMID:
12458664
16.

Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo.

Scherer F, Schillinger U, Putz U, Stemberger A, Plank C.

J Gene Med. 2002 Nov-Dec;4(6):634-43.

PMID:
12439855
17.

The role of growth factors in the repair of bone. Biology and clinical applications.

Lieberman JR, Daluiski A, Einhorn TA.

J Bone Joint Surg Am. 2002 Jun;84-A(6):1032-44. Review. No abstract available.

PMID:
12063342
19.

Clinical evaluation of recombinant human bone morphogenetic protein-2.

Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE.

Clin Orthop Relat Res. 2002 Feb;(395):110-20. Review.

PMID:
11937870
20.

Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors.

Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M.

J Biomed Mater Res. 2001;58(4):449-55.

PMID:
11410904

Supplemental Content

Support Center